# 神经介入设备市场

> 神经介入设备市场研究报告按类型（静脉导管、球囊导管、支架、线圈栓塞、动脉瘤夹）、按应用（动脉瘤、动静脉畸形、颅内动脉粥样硬化疾病、缺血性中风）、按最终用途（医院、门诊手术中心、专科诊所）、按程序类型（诊断、治疗）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.01%
- **2024:** $ 2.18 Billion
- **2025:** $ 2.33 Billion
- **2035:** $ 4.6 Billion
- **Key Players:** Medtronic (US), Stryker (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Penumbra (US), MicroVention (US), Asahi Intecc (JP), NeuroVasc Technologies (US)

**Report ID:** MRFR/HC/32073-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** October 16, 2026

**URL:** https://www.marketresearchfuture.com/reports/neurointerventional-device-market-33911

---

## Market Summary

## **Neurointerventional Device Market Overview**

As per MRFR analysis, the Neurointerventional Device Market Size was estimated at 2.18 (USD Billion) in 2024. The Neurointerventional Device Market Industry is expected to grow from 2.33 (USD Billion) in 2025 to 4.30 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.01% during the forecast period (2025 - 2034).

### **Key Neurointerventional Device Market Trends Highlighted**

The global neuro-interventional device market is experiencing significant growth driven by an increase in the incidence of neurological disorders such as stroke, aneurysms, and arteriovenous malformations. Technological advancements in imaging and surgical procedures enhance the efficacy and safety of neuro-interventional therapies. Further, the growing aging population and rising awareness of minimally invasive procedures are propelling the demand for these devices.

Hospitals and surgical centers are increasingly adopting these technologies due to their benefits, which include shorter recovery times and reduced complications versus traditional methods.Opportunities are becoming evident in the development of next-generation neuro interventional devices that offer enhanced precision and safety.

Emerging markets present a vast potential for growth as healthcare infrastructure improves and more patients gain access to advanced treatments. Additionally, increasing investments in research and development can lead to innovations that meet diverse patient needs and improve procedural outcomes.

Collaborations between device manufacturers and healthcare providers may create new pathways for the development of tailored solutions. In recent times, there has been a clear trend toward the integration of digital technologies, such as artificial intelligence and machine learning, into neuro-interventional procedures. This enhances decision-making and patient monitoring.

Furthermore, telemedicine is gaining traction, allowing specialists to consult remotely, which is especially beneficial in areas with limited access to expert care. As a result, the neuro-interventional device market is evolving, focusing on improving patient outcomes, streamlining workflows, and enhancing overall treatment effectiveness. The continuous evolution of device capabilities and procedural techniques indicates a promising future for the market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Neurointerventional Device Market Drivers**

### Technological Advancements Leading to Enhanced Procedure Outcomes

Technological advancements in neuro-interventional systems significantly drive the Global Neurointerventional Device Market Industry. With the continuous evolution of imaging techniques, such as 3D imaging, and the introduction of minimally invasive surgical methods, neuro-interventional devices have become more effective and safer for patients. Innovations in device design, materials, and engineering have resulted in enhanced precision during procedures, reducing complications and improving recovery times for patients.

This has led to increased adoption of neuro-interventional devices in clinical settings. Furthermore, the integration of artificial intelligence and machine learning in neuro-interventional procedures is facilitating more accurate diagnostics and treatment planning, contributing to better patient outcomes.

Hospitals and surgical centers are increasingly investing in these advanced technologies, anticipating better operational efficiencies and patient care, which is fuelling growth in the Global Neurointerventional Device Market.As healthcare providers strive to implement state-of-the-art technologies, the demand for innovative neuro-interventional devices is expected to surge, propelling the market steadily forward.

### Rising Incidence of Neurological Disorders

The increase in the prevalence of neurological disorders, such as stroke, aneurysms, and arteriovenous malformations (AVMs), is a critical driver of growth in the Global Neurointerventional Device Market Industry. As the incidence of these conditions rises globally, healthcare systems are prioritizing the development and implementation of effective interventional therapies to provide timely treatment.

Additionally, an aging population is contributing to a higher demand for neuro-interventional devices, as older individuals are more susceptible to neurological issues.The greater awareness of stroke symptoms and the need for rapid intervention are leading to increased utilization of neuro-interventional procedures. Continued research is also revealing the benefits of neurointervention in managing complex neurological conditions, further driving the demand for these specialized devices.

### Growing Investments and Funding in Healthcare Technology

Investment in healthcare technology, particularly in the development of neuro-interventional devices, is a notable driver behind the growth of the Global Neurointerventional Device Market Industry. Venture capital funding, government grants, and corporate investments are all contributing to the innovation and commercialization of advanced neurointerventional technologies.

This influx of capital is enabling companies to undertake extensive research and development efforts, resulting in more effective, patient-friendly devices entering the market.Additionally, funding is essential for clinical trials, which are necessary for regulatory approvals and the eventual adoption of new technologies by healthcare institutions. As investors recognize the potential returns in the neurointerventional sector, this trend is likely to enhance the quality and quantity of devices available to practitioners, further advancing the market.

## **Neurointerventional Device Market Segment Insights**

### **Neurointerventional Device Market Type Insights**

The Global Neurointerventional Device Market, set to reach a valuation of 1.9 USD Billion in 2023, showcases a diverse segmentation, particularly within the Type category, which encompasses critical devices like Intravenous Catheters, Balloon Catheters, Stents, Coil Embolization, and Aneurysm Clips.

The Intravenous Catheters segment held a valuation of 0.4 USD Billion in 2023, projected to grow to 0.75 USD Billion by 2032, indicating its significant role in neuro-interventional procedures where access to the vascular system is paramount.

Balloon Catheters, valued at 0.3 USD Billion in 2023 and expected to rise to 0.55 USD Billion by 2032, play a crucial function in lesion dilation during interventions, showcasing a steady demand in the market.Stents, currently valued at 0.5 USD Billion and anticipated to double to 1.0 USD Billion by 2032, dominate the segment due to their importance in maintaining vascular patency and preventing vessel collapse, thereby playing a vital role in stroke management and other critical conditions.

Similarly, Coil Embolization, also valued at 0.5 USD Billion in 2023 with a future projection of 1.0 USD Billion, remains a significant component, primarily utilized in the treatment of aneurysms, highlighting its essentiality in minimizing procedural risks and enhancing patient outcomes.The Aneurysm Clips segment, although smaller, with a valuation of 0.2 USD Billion in 2023 and expected to reach 0.4 USD Billion by 2032, signifies the unique niche it fills in surgical interventions for aneurysms, demonstrating a specialized yet vital aspect of neuro-interventional procedures.

This complete overview of the Global Neurointerventional Device Market segmentation underscores the critical importance of these devices in both therapeutic and preventive strategies for neurovascular pathologies, driving advancements in treatment modalities while catering to an evolving patient demographic.The growth trajectories observed across these device types reveal significant opportunities driven by technological innovations, the rising prevalence of neurovascular disorders, and increasing awareness regarding minimally invasive procedures, further propelling market growth as healthcare professionals seek to employ more effective and safer intervention techniques.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Neurointerventional Device Market Application Insights**

The Global Neurointerventional Device Market, valued at USD 1.9 billion in 2023, is witnessing substantial growth driven by advancements in technology and the increasing prevalence of neurological disorders. The Applications within this market include critical areas such as Aneurysms, Arteriovenous Malformation, Intracranial Atherosclerotic Disease, and [Ischemic Stroke](../../../reports/ischemic-stroke-market-5423), which together form a significant portion of overall market dynamics.

Aneurysm treatment is essential due to the life-threatening nature of this condition, demonstrating a major demand for neuro-interventional devices.Arteriovenous Malformations hold a noteworthy position as they can lead to significant complications, thus requiring effective intervention techniques.

Intracranial Atherosclerotic Disease is on the rise, correlating with lifestyle changes and increasing market growth opportunities. Additionally, Ischemic Stroke is a leading cause of mortality worldwide, prompting innovations in neuro-interventional solutions, thereby reinforcing its status as a vital aspect of the market.

The projected growth reflects the urgency for effective treatment and preventive strategies across these applications, shaping the future landscape of the Global Neurointerventional Device Market.With a strong annual growth rate anticipated, the market trends suggest ongoing developments that will further address the challenges and requirements of these critical applications, making it an exciting period for the industry.

### **Neurointerventional Device Market End-Use Insights**

The Global Neurointerventional Device Market reached a valuation of 1.9 billion USD by 2023, with significant contributions coming from various end-use settings such as hospitals, ambulatory surgical centers, and specialty clinics. Hospitals are critical in this market, as they typically offer a wide range of neuro-interventional procedures and have advanced resources to manage complex cases.

Ambulatory surgical centers are also gaining traction due to their ability to provide same-day discharge procedures, thereby enhancing patient convenience and reducing overall healthcare costs.Specialty clinics cater specifically to neuro-interventional care and are becoming increasingly significant as they focus on specialized treatments that may offer more innovative solutions to patient needs.

The growing demand for minimally invasive procedures and advancements in technology are driving growth in these areas, while challenges like regulatory hurdles and high costs of advanced devices may influence market dynamics. Overall, the Global Neurointerventional Device Market segmentation reflects a diverse landscape that supports tailored healthcare solutions across different settings.

### **Neurointerventional Device Market Procedure Type Insights**

The Global Neurointerventional Device Market revenue is substantial, with a valuation of 1.9 USD Billion in 2023, reflecting robust demand across various procedure types. The market is primarily segmented into Diagnostic and Therapeutic, each playing a crucial role in advancing neuro-interventional techniques. The Diagnostic segment is essential for accurately diagnosing neurological conditions and aids clinicians in determining appropriate treatment paths, which contributes to the significant growth within the sector.

On the other hand, the Therapeutic segment is pivotal as it addresses a variety of severe conditions, including stroke and aneurysms, thus significantly driving market growth.These segments illustrate the importance of specialized procedures in improving patient outcomes, with the demand for advanced neurointerventional devices anticipated to grow.

The dynamics within the Global Neurointerventional Device Market data showcase an evolving landscape characterized by technological advancements and increasing investments aimed at enhancing procedural success rates. With rising awareness of neurovascular diseases and innovations in medical technology, opportunities for expansion within these segments are noteworthy as they cater to an urgent need for effective treatments in the industry.

### **Neurointerventional Device Market Regional Insights**

The Global Neurointerventional Device Market is valued at 1.9 billion USD in 2023 and is expected to experience significant growth in the coming years. Notably, North America holds the majority share, valued at 0.95 billion USD in 2023, and is projected to reach 1.75 billion USD by 2032, driven by advanced healthcare infrastructure and high adoption rates of innovative procedures.

Europe followed as a significant player, with a valuation of 0.55 billion USD in 2023, and is anticipated to grow to 1.05 billion USD, indicating robust market potential due to increasing awareness and investment in neuro-interventional treatments.In contrast, the APAC region, valued at 0.25 billion USD, is gradually expanding to 0.55 billion USD, showcasing emerging opportunities in developing countries.

Meanwhile, South America and MEA hold smaller shares at 0.1 billion USD and 0.15 billion USD, respectively, in 2023 but are also expected to witness growth, primarily driven by improving healthcare access and rising investment in medical technology. The market growth across these regions presents various challenges and opportunities, such as regulatory hurdles and the need for skilled professionals, which may impact market dynamics and patient access to neuro-interventional procedures.

****

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Neurointerventional Device Market Key Players and Competitive Insights**

The Global Neurointerventional Device Market is characterized by rapid advancements in technology and a growing emphasis on minimally invasive techniques for the treatment of neurological conditions such as stroke and aneurysms. This market has seen a surge in product offerings aimed at enhancing patient outcomes, reducing recovery times, and improving procedural efficiency. Competitive insights reveal a landscape marked by innovation, with key players continuously investing in research and development to bring forth novel solutions that address the complexities of neurovascular diseases.

As demographics shift and the prevalence of neurological disorders rises, companies within this sector are vying for market share by expanding their product portfolios and improving their distribution networks. Strategic collaborations, mergers and acquisitions, and regional expansions are common tactics employed by market participants to establish a robust presence and cater to diverse clinical needs globally.

Stryker Corporation is a prominent player in the Global Neurointerventional Device Market, recognized for its commitment to innovation and quality. The company's extensive product lineup includes advanced technologies for thrombus removal, vascular access, and neurovascular embolization, which have significantly contributed to improving patient outcomes in critical procedures. Stryker's strong emphasis on research and development positions it as a leader in introducing cutting-edge solutions that address unsolved challenges in neurosurgery.

Additionally, the company benefits from a comprehensive global distribution network and strategic partnerships with medical practitioners and institutions, which helps ensure its products are widely accessible to healthcare providers around the world. This operational strength, combined with Stryker's commitment to continuous improvement, has solidified its reputation and position within the neurointerventional space.

Boston Scientific is another key player in the Global Neurointerventional Device Market, with a strong focus on developing innovative technologies for the treatment of complex neurovascular conditions. The company has established itself through its dedication to enhancing the efficacy of neuro-interventional procedures and improving overall patient care. Boston Scientific's product offerings encompass a range of devices that facilitate procedures such as mechanical thrombectomy and stenting, critical for treating strokes and other vascular disorders.

The company's activities in research and development are geared towards pioneering advanced products that provide clinicians with superior options during interventions. Their comprehensive market presence is further strengthened by collaborations with leading healthcare institutions and thought leaders, ensuring that Boston Scientific remains at the forefront of advancements in neuro-interventional therapies while responding effectively to emerging clinical needs.

### **Key Companies in the neuro-interventional Device Market Include**

- Stryker Corporation
- Boston Scientific
- Medtronic
- **[Abbott Laboratories](https://www.abbott.com/for-healthcare-professionals/neuromodulation.html)**
- Soham International
- Evasc
- Terumo Corporation
- Aneurysm Clip Company
- NeuroTechnology Innovations
- Asahi Intecc
- Penumbra
- Johnson and  Johnson
- Cerenovus
- MicroVention
- Codman and  Shurtleff

## Neurointerventional Device Market Industry Developments

- **Q2 2024: Stryker launches new Target Tetra Detachable Coil for neurovascular procedures** Stryker announced the launch of its Target Tetra Detachable Coil, designed for the treatment of brain aneurysms, expanding its neurovascular product portfolio.
- **Q2 2024: Penumbra Announces FDA Clearance and U.S. Launch of RED Reperfusion Catheters for Stroke Treatment** Penumbra received FDA clearance and launched its RED Reperfusion Catheters in the U.S., intended for use in the removal of clots in patients with acute ischemic stroke.
- **Q2 2024: MicroVention, Inc. Receives FDA Approval for LVIS EVO Stent System for Intracranial Aneurysm Treatment** MicroVention, a Terumo company, announced FDA approval of its LVIS EVO Stent System, expanding treatment options for patients with wide-neck intracranial aneurysms.
- **Q2 2024: Cerus Endovascular Announces CE Mark Approval for 027 Microcatheter-Compatible Contour Neurovascular System** Cerus Endovascular received CE Mark approval for its 027 Microcatheter-Compatible Contour Neurovascular System, enabling broader access to its intrasaccular device for treating intracranial aneurysms in Europe.
- **Q2 2024: Rapid Medical Announces FDA Clearance of TIGERTRIEVER 13 for Stroke Treatment** Rapid Medical received FDA clearance for its TIGERTRIEVER 13 device, a stent retriever designed for mechanical thrombectomy in stroke patients.
- **Q2 2024: Wallaby Medical Completes Acquisition of Phenox GmbH** Wallaby Medical, a global medical device company, completed its acquisition of Phenox GmbH, expanding its neurovascular product offerings and European presence.
- **Q3 2024: Imperative Care Raises $260 Million in Series D Financing to Advance Stroke Care Technologies** Imperative Care, a medical technology company focused on stroke care, raised $260 million in Series D funding to accelerate development and commercialization of its neurointerventional devices.
- **Q3 2024: Medtronic Receives FDA Approval for Pipeline Vantage Embolization Device with Shield Technology** Medtronic announced FDA approval of its Pipeline Vantage Embolization Device with Shield Technology, designed for the treatment of brain aneurysms.
- **Q3 2024: Balt Receives FDA Approval for Silk Vista Flow Diverter for Intracranial Aneurysms** Balt announced FDA approval of its Silk Vista Flow Diverter, a device intended for the endovascular treatment of intracranial aneurysms.
- **Q3 2024: Route 92 Medical Announces FDA Clearance of FreeClimb 88 Access System for Neurointerventional Procedures** Route 92 Medical received FDA clearance for its FreeClimb 88 Access System, designed to facilitate neurointerventional procedures for stroke and aneurysm treatment.
- **Q3 2024: Stryker Completes Acquisition of Cerus Endovascular** Stryker completed the acquisition of Cerus Endovascular, strengthening its neurovascular portfolio with innovative intrasaccular aneurysm treatment devices.
- **Q3 2024: Penumbra Appoints Dr. Lisa W. Miller as Chief Medical Officer** Penumbra announced the appointment of Dr. Lisa W. Miller as Chief Medical Officer, bringing extensive neurointerventional experience to the executive team.

This growth is not only reshaping market dynamics but is also attracting investments, further fueling innovation in neuro-interventional therapies. The ongoing developments show a promising outlook for the industry as it navigates through opportunities for expansion and modernization.

## **Neurointerventional Device Market Segmentation Insights**

### **Neurointerventional Device Market Type Outlook**

- Intravenous Catheters
- Balloon Catheters
- Stents
- Coil Embolization
- Aneurysm Clips

### **Neurointerventional Device Market Application Outlook**

- Aneurysm
- Arteriovenous Malformation
- Intracranial Atherosclerotic Disease
- Ischemic Stroke

### **Neurointerventional Device Market End-Use Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics

### **Neurointerventional Device Market Procedure Type Outlook**

- Diagnostic
- Therapeutic

### **Neurointerventional Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### 增加医疗支出

不断上升的医疗支出是神经介入设备市场的重要驱动因素。随着各国将更多资源分配给医疗保健，先进医疗技术的资金也相应增加。这一趋势在政府优先治疗神经系统疾病的地区尤为明显。对医疗基础设施和技术的投资增加，可能会导致神经介入设备的更大采用。此外，随着医疗系统的发展，越来越强调能够改善患者结果的成本效益解决方案，而神经介入设备正好能够提供这样的解决方案。

### 监管合作与批准

神经介入设备市场受益于持续的监管合作，这些合作促进了新设备的批准。监管机构越来越多地与制造商合作，以简化批准流程，确保创新设备更高效地进入市场。这种合作至关重要，因为它鼓励对研究和开发的投资，导致尖端技术的引入。市场上获得批准的设备数量正在增加，这可能会增强竞争并降低成本，最终使医疗服务提供者和患者都受益。

### 日益增长的意识和教育

神经介入设备市场也受到对神经系统疾病及其治疗方案的日益关注和教育的推动。医疗专业人员对神经介入程序的好处的认识不断提高，导致患者的转诊率上升。公众意识宣传活动也在帮助患者了解可用的治疗方案，这可能导致更早的诊断和干预。随着意识的提高，预计对神经介入设备的需求将上升，因为患者寻求针对其神经系统疾病的先进治疗方案。

### 神经介入设备的技术进步

神经介入设备市场正在经历快速的技术进步，这些进步提高了手术的有效性和安全性。先进的成像技术、机器人辅助系统和微创工具等创新正在改变治疗方案。例如，人工智能在成像分析中的整合正在提高诊断准确性，这对及时干预至关重要。预计市场将显著增长，估计未来几年复合年增长率将超过8%。这些进展不仅改善了患者的治疗结果，还扩大了可治疗疾病的范围，从而推动了对神经介入设备的需求。

### 神经系统疾病发病率上升

神经系统疾病的日益普遍是神经介入设备市场的主要驱动因素。中风、动脉瘤和动静脉畸形等疾病变得越来越常见，迫切需要有效的治疗方案。根据最新数据，中风发生率预计将上升，从而对神经介入手术的需求增加。这一趋势因老龄化人口而进一步加剧，老年人更易患神经系统疾病。随着医疗系统寻求应对这些挑战，创新的神经介入设备的需求预计将激增，从而推动市场增长。

## Future Outlook

神经介入设备市场预计将在2024年至2035年间以7.01%的年均增长率增长，推动因素包括技术进步、神经系统疾病的日益普遍以及医疗支出的增加。

**New opportunities:**

- 开发先进的神经血管支架以改善患者的治疗效果。 整合人工智能驱动的成像系统以提高手术精确度。 进入新兴市场，提供量身定制的产品。

到2035年，神经介入设备市场预计将实现显著增长和创新。

## Segment Insights

### 按类型：支架（最大）与线圈栓塞（增长最快）

神经介入设备市场的特点是多样的细分领域，如静脉导管、气囊导管、支架、线圈栓塞和动脉瘤夹。在这些细分领域中，支架占据了最大的市场份额，因其在治疗各种神经血管疾病中的有效性和可靠性而被广泛使用。同时，线圈栓塞已成为增长最快的细分领域，这得益于微创手术的不断进步和神经系统疾病的日益普遍，导致临床实践中的采用率提高。随着市场的发展，多个增长驱动因素影响着这些细分领域。支架因其耐用性和效率而受到青睐，这在处理复杂病例如动脉瘤时至关重要。相反，线圈栓塞的快速扩展是由技术创新推动的，例如改进的输送系统和生物相容材料，提高了安全性和患者的治疗效果。随着制造商努力创新，竞争格局不断变化，为成熟和新兴技术创造了动态环境。

支架（主导）与线圈栓塞（新兴）

支架在神经介入设备市场中至关重要，以其强度和可靠性而闻名，能够解决各种脑血管问题。其技术进步使其成为许多神经介入手术的主导选择，尤其是在颈动脉和颅内动脉的支架植入方面。支架在患者结果方面的显著关注，使其在设计上追求最佳性能，确保长期有效性。相反，线圈栓塞代表了市场中的一种新兴趋势，反映出向更少侵入性治疗选项的转变。这种技术利用线圈来封闭动脉瘤和血管畸形，其快速采用得益于持续的创新，旨在提高手术效率和安全性。随着医疗服务提供者越来越重视缩短患者恢复时间和优化治疗成功率，线圈栓塞预计将在未来几年内见证显著增长。

### 按应用：动脉瘤（最大）与缺血性中风（增长最快）

神经介入设备市场受到其应用细分领域的显著影响，其中动脉瘤治疗成为主导力量。该细分领域由于动脉瘤的高发病率和神经介入技术的进步而占据最大的市场份额。相比之下，颅内动脉粥样硬化疾病和动静脉畸形细分领域也对市场有所贡献，但份额较小，表明医疗界的关注更加专业化。至于增长趋势，缺血性中风治疗在神经介入设备市场中正经历最快的增长。这一激增是由于对中风治疗选择的认识提高、技术进步以及全球缺血性中风发生率上升所驱动。对创新解决方案的需求以治疗急性中风病例，确保了该应用细分领域的市场环境充满活力。

动脉瘤：缺血性中风与非缺血性中风：新兴

在神经介入设备市场中，动脉瘤治疗是主要应用，因为其广泛的认可度和稳健的程序框架。为动脉瘤干预开发的设备已经成熟，并经历了多种创新，使其对临床医生而言可靠。另一方面，缺血性中风应用正在迅速崛起，受到血管内技术进步和对新治疗方法投资增加的推动。更好的成像技术和对中风病理生理学的更深入理解，导致了患者结果的改善。对缺血性中风日益重视，突显了神经介入实践中的关注焦点转变，在及时干预至关重要的情况下，使其在未来市场增长中处于有利位置。

### 按最终用途：医院（最大）与门诊手术中心（增长最快）

神经介入设备市场受到其最终用途分布的显著影响，医院因其先进的基础设施和专业护理团队而占据主导份额。医院不仅服务于大量患者群体，还能接触到最新技术，从而提升其市场份额。门诊手术中心（ASC）紧随其后，由于其对神经学门诊程序的日益关注而变得越来越重要，增强了患者的便利性并降低了整体医疗成本。

医院（主导）与门诊手术中心（新兴）

医院仍然是神经介入设备市场的主要终端使用部门，这主要得益于它们能够满足复杂神经介入手术的全面设施。凭借先进的技术和多学科团队，医院能够提供广泛的护理，影响神经介入设备的更高使用率。然而，门诊手术中心正在迅速崛起，为患者提供在成本效益高的环境中进行较少侵入性手术的机会。门诊手术中心正在采用针对门诊服务的创新设备，提高患者的流量和满意度，并在市场中展现出良好的增长潜力。

### 按程序类型：诊断（最大）与治疗（增长最快）

在神经介入设备市场中，程序类型的分布显示，诊断细分市场占据主导地位，拥有显著的市场份额。该细分市场涵盖了一系列对神经血管疾病进行准确诊断所必需的程序，帮助医疗服务提供者做出明智的治疗决策。另一方面，治疗细分市场虽然整体份额较小，但随着治疗技术和方法的进步，正在迅速获得动力。

程序类型：诊断（主导）与治疗（新兴）

诊断程序类型在神经介入设备市场中显得尤为重要，专注于神经血管疾病的成像和评估。该细分市场已稳固建立，得到了大量旨在提高诊断准确性的设备的支持。相对而言，治疗细分市场正在迅速崛起，受到微创技术创新的推动，这些技术能够有效治疗复杂的病症，如动脉瘤和动静脉畸形。因此，治疗细分市场吸引了相当大的关注和投资，正逐渐成为与根深蒂固的诊断细分市场相对的动态对手。

## Regional Market Share Analysis

### 北美：创新与市场领导

北美是神经介入设备最大的市场，约占全球市场份额的45%。该地区受益于先进的医疗基础设施、高发病率的神经系统疾病以及对研发的重大投资。FDA等机构的监管支持进一步促进了市场增长，确保创新设备的快速批准。美国是该领域的领先国家，主要参与者如美敦力、史赛克和波士顿科学推动了竞争。成熟的医疗系统和对微创手术的关注是该地区主导地位的关键因素。加拿大也发挥着重要作用，其医疗设施中神经介入技术的采用不断增加。

### 欧洲：具有增长潜力的新兴市场

欧洲是神经介入设备的第二大市场，约占全球市场份额的30%。由于老龄化人口和中风及其他神经系统疾病的发病率上升，该地区的需求正在激增。医疗器械法规（MDR）等监管框架正在不断发展，以支持创新，同时确保患者安全。主要国家包括德国、法国和英国，这些国家的医疗投资非常强劲。像Terumo Corporation和强生这样的主要参与者正在扩大他们的市场份额，增强竞争。欧洲市场的特点是成熟公司与新兴初创企业的结合，促进了创新并改善了患者的治疗结果。

### 亚太地区：快速增长与采用

亚太地区正在迅速崛起为神经介入设备市场的重要参与者，约占全球市场份额的20%。该地区的增长受到医疗支出增加、对神经血管疾病认识提高以及医疗技术进步的推动。中国和印度等国的神经介入手术需求激增，得益于政府的有利政策和对医疗基础设施的投资。中国是该地区最大的市场，越来越多的医院采用先进的神经介入技术。竞争格局正在演变，本地和国际参与者如Asahi Intecc和MicroVention都在努力争夺市场份额。对改善医疗服务的可及性和质量的关注正在推动市场向前发展。

### 中东和非洲：未开发的潜力与挑战

中东和非洲地区代表了神经介入设备的新兴市场，约占全球市场份额的5%。增长主要受到医疗投资增加、对神经系统疾病认识提高以及专业医疗设施建立的推动。然而，有限的先进医疗技术获取和不同的监管环境等挑战阻碍了市场扩展。南非和阿联酋等国在采用神经介入技术方面走在前列，越来越多的医疗提供者投资于先进设备。竞争格局正在逐渐演变，本地和国际公司都在寻求在这一未开发市场中建立立足点，专注于改善患者护理和治疗结果。

## Competitive Benchmarking

神经介入设备市场的特点是动态的竞争格局，受到技术进步和神经系统疾病日益普遍的推动。主要参与者如美敦力（美国）、史赛克（美国）和波士顿科学（美国）处于前沿，各自采取不同的策略来增强市场定位。美敦力（美国）通过持续的产品开发强调创新，特别是在微创技术方面，而史赛克（美国）则专注于战略收购以增强其产品组合。波士顿科学（美国）似乎正在利用合作伙伴关系扩大其在新兴市场的影响力，从而塑造一个日益合作但竞争激烈的竞争环境。

在商业策略方面，公司正在本地化制造以降低成本并提高供应链效率。神经介入设备市场适度分散，既有成熟企业也有新兴公司。这种分散性允许多样化的产品供应，但也加剧了主要参与者之间的竞争，因为他们通过创新和运营卓越争夺市场份额。

2025年8月，美敦力（美国）宣布推出一种新的神经血管支架，旨在改善中风治疗中的患者结果。这一战略举措不仅强化了美敦力对创新的承诺，还使公司能够在不断增长的中风干预市场中占据更大份额。该产品的推出可能会通过满足未满足的临床需求来增强美敦力的竞争优势。

2025年9月，史赛克（美国）完成了对一家领先的神经血管技术公司的收购，预计将显著增强其在神经介入领域的产品供应。这一收购反映了史赛克巩固市场地位和扩展技术能力的战略，可能导致改善患者结果和增加市场渗透率。

2025年7月，波士顿科学（美国）与一家知名研究机构达成战略合作，开发下一代神经介入设备。这一合作表明公司专注于通过研究和开发实现创新，这可能会产生解决当前神经介入程序局限性的尖端解决方案。

截至2025年10月，神经介入设备市场正在见证数字化、可持续性和人工智能整合等趋势。这些趋势正在重塑竞争动态，公司越来越多地形成战略联盟，以利用共享的专业知识和资源。竞争差异化可能会从传统的基于价格的竞争演变为关注创新、技术进步和供应链可靠性，这表明未来优先考虑这些要素的公司将会蓬勃发展。

## Recent News & Developments

- **2024年第二季度：Stryker推出用于神经血管手术的新型Target Tetra可拆卸线圈**Stryker宣布推出其Target Tetra可拆卸线圈，旨在治疗脑动脉瘤，扩展其神经血管产品组合。
- **2024年第二季度：Penumbra宣布FDA批准并在美国推出RED再灌注导管用于中风治疗**Penumbra获得FDA批准并在美国推出其RED再灌注导管，旨在用于去除急性缺血性中风患者的血栓。
- **2024年第二季度：MicroVention, Inc.获得FDA批准用于颅内动脉瘤治疗的LVIS EVO支架系统**MicroVention，一家Terumo公司，宣布获得FDA批准其LVIS EVO支架系统，扩展了对宽颈颅内动脉瘤患者的治疗选择。
- **2024年第二季度：Cerus Endovascular宣布获得CE标记批准的027微导管兼容轮廓神经血管系统**Cerus Endovascular获得CE标记批准，其027微导管兼容轮廓神经血管系统，使其在欧洲治疗颅内动脉瘤的囊内装置获得更广泛的使用。
- **2024年第二季度：Rapid Medical宣布获得FDA批准的TIGERTRIEVER 13用于中风治疗**Rapid Medical获得FDA批准其TIGERTRIEVER 13设备，这是一种用于中风患者机械取栓的支架取栓器。
- **2024年第二季度：Wallaby Medical完成对Phenox GmbH的收购**Wallaby Medical，一家全球医疗设备公司，完成对Phenox GmbH的收购，扩展其神经血管产品供应和在欧洲的业务。
- **2024年第三季度：Imperative Care在D轮融资中筹集2.6亿美元以推进中风护理技术**Imperative Care，一家专注于中风护理的医疗技术公司，在D轮融资中筹集了2.6亿美元，以加速其神经介入设备的开发和商业化。
- **2024年第三季度：Medtronic获得FDA批准的Pipeline Vantage栓塞装置，配备Shield技术**Medtronic宣布获得FDA批准其Pipeline Vantage栓塞装置，配备Shield技术，旨在治疗脑动脉瘤。
- **2024年第三季度：Balt获得FDA批准的Silk Vista流量分流器用于颅内动脉瘤**Balt宣布获得FDA批准其Silk Vista流量分流器，这是一种用于颅内动脉瘤的血管内治疗装置。
- **2024年第三季度：Route 92 Medical宣布获得FDA批准的FreeClimb 88接入系统用于神经介入手术**Route 92 Medical获得FDA批准其FreeClimb 88接入系统，旨在促进中风和动脉瘤治疗的神经介入手术。
- **2024年第三季度：Stryker完成对Cerus Endovascular的收购**Stryker完成对Cerus Endovascular的收购，增强其神经血管产品组合，提供创新的囊内动脉瘤治疗装置。
- **2024年第三季度：Penumbra任命Dr. Lisa W. Miller为首席医疗官**Penumbra宣布任命Dr. Lisa W. Miller为首席医疗官，为执行团队带来了丰富的神经介入经验。

这一增长不仅重塑了市场动态，还吸引了投资，进一步推动了神经介入治疗的创新。持续的发展为行业展现了一个充满希望的前景，因为它在扩展和现代化的机会中不断前行。

## Report Scope

| 2024年市场规模 | 2.181（十亿美元） |
| --- | --- |
| 2025年市场规模 | 2.334（十亿美元） |
| 2035年市场规模 | 4.597（十亿美元） |
| 复合年增长率（CAGR） | 7.01%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 微创技术的进步增强了神经介入设备市场的增长潜力。 |
| 主要市场动态 | 技术进步和监管变化推动了神经介入设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，神经介入设备市场的预计市场估值是多少？**
A: 神经介入设备市场预计到2035年将达到约45.97亿美元。

**Q: 2024年神经介入设备市场的市场估值是多少？**
A: 2024年，神经介入设备市场的价值为21.81亿美元。

**Q: 在2025年至2035年的预测期内，神经介入设备市场的预期CAGR是多少？**
A: 神经介入设备市场在2025年至2035年预测期内的预期CAGR为7.01%。

**Q: 在神经介入设备市场中，哪些公司被视为关键参与者？**
A: 神经介入设备市场的主要参与者包括美敦力、史赛克、波士顿科学和泰尔茂公司。

**Q: 到2035年，神经介入设备市场的哪个细分领域预计将拥有最高的估值？**
A: 预计到2035年，治疗程序类型细分市场将达到约32.05亿美元。

**Q: 2024年和2035年静脉导管的估值如何比较？**
A: 预计静脉导管的估值将从2024年的5亿美元增加到2035年的9亿美元。

**Q: 2024年至2035年，动脉瘤应用领域的预期增长是多少？**
A: 动脉瘤应用领域预计将从2024年的6.54亿美元增长到2035年的13.92亿美元。

**Q: 到2035年，专科诊所的预期市场规模是多少？**
A: 到2035年，专科诊所的市场规模预计将达到约13.6亿美元。

**Q: 到2035年，预计哪个最终用途细分市场的估值最高？**
A: 医院终端使用细分市场预计将具有最高的估值，到2035年将达到约18.45亿美元。

**Q: 到2035年，线圈栓塞细分市场的预计估值是多少？**
A: 线圈栓塞细分市场预计将从2024年的4亿美元增长到2035年的9亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/neurointerventional-device-market-33911*